Advertisement

Topics

AZ Rides PACIFIC Wave To Be First In Early-Stage NSCLC

21:53 EDT 10 Sep 2017 | SCRIP

After Imfinzi's failure in the MYSTIC trial, AstraZeneca is very much back in the lung cancer game following the success...

      

Related Stories

 

Original Article: AZ Rides PACIFIC Wave To Be First In Early-Stage NSCLC

NEXT ARTICLE

More From BioPortfolio on "AZ Rides PACIFIC Wave To Be First In Early-Stage NSCLC"

Quick Search
Advertisement
 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...